Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database / Brown, J. R.; Ghia, P.; Jurczak, W.; Kahl, B. S.; Lamanna, N.; Robak, T.; Shadman, M.; Tam, C. S.; Qiu, L.; Paik, J.; Salmi, T.; Wang, L.; Zhang, J.; Zhang, M.; Cohen, A.; Ma, H.; Tedeschi, A.. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 109:7(2024), pp. 2277-2283. [10.3324/haematol.2023.283846]
Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database
Ghia P.
;
2024-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
